By this time next year, the world's biggest cloning facility will be operational next year but they won't be employing any of Victor Frankenstein's methods, a chief executive of the Chinese company behind the project promised.
Biotech company Boyalife Group's $30 million facility in the coastal city of Tianjin will produce embryos of cattle as well as racehorses and contraband-sniffing dogs when it becomes operational next year.
"No, we don't do human cloning, we won't make Frankensteins," said Dr. Xu Xiaochun, its chief executive, referring to Frankenstein's monster in Mary Shelley's novel.
